We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+10.97%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$19B
AUM Growth
+$4.37B
(+30%)
Cap. Flow
+$3.05B
Cap. Flow
% of AUM
16.07%
Top 10 Holdings %
Top 10 Hldgs %
39.91%
Holding
1,362
New
110
Increased
730
Reduced
452
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$492M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$263M |
| 3 |
Qualcomm
QCOM
|
+$143M |
| 4 |
Broadcom
AVGO
|
+$118M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$81.8M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$18.6M |
| 3 |
Chevron
CVX
|
+$11.9M |
| 4 |
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
|
+$10.9M |
| 5 |
ExxonMobil
XOM
|
+$8.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.28% |
| 2 | Financials | 15.39% |
| 3 | Healthcare | 5.04% |
| 4 | Energy | 4.05% |
| 5 | Consumer Discretionary | 2.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDMO
376
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $5.25M | 0.03% |
179,962
+63,572
| +55% | +$1.82M |
|
|
VG
377
DELISTED
Vonage Holdings Corporation
VG
| $5.19M | 0.03% |
249,836
+15,372
| +7% | +$280K |
|
|
NVTA
378
DELISTED
Invitae Corporation
NVTA
| $5.18M | 0.03% |
339,131
+223,536
| +193% | +$4.83M |
|
|
EXAS
379
DELISTED
Exact Sciences
EXAS
| $5.18M | 0.03% |
66,501
+36,431
| +121% | +$3.22M |
|
380
Arrowhead Research
ARWR
$11.9B
| $5.15M | 0.03% |
77,725
+29,024
| +60% | +$1.99M |
|
381
Vericel Corp
VCEL
$2.35B
| $5.13M | 0.03% |
130,467
+70,106
| +116% | +$3.07M |
|
382
Heron Therapeutics
HRTX
$93.9M
| $5.12M | 0.03% |
561,277
+293,809
| +110% | +$3M |
|
383
Arcus Biosciences
RCUS
$3.55B
| $5.11M | 0.03% |
126,318
+43,988
| +53% | +$1.71M |
|
384
Xcel Energy
XEL
$48.8B
| $5.1M | 0.03% |
75,340
-10,207
| -12% | -$665K |
|
385
Trex
TREX
$4.51B
| $5.09M | 0.03% |
37,672
+557
| +2% | +$66.9K |
|
|
ATH
386
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $5.08M | 0.03% |
60,912
+5,472
| +10% | +$449K |
|
387
Vir Biotechnology
VIR
$1.46B
| $5.06M | 0.03% |
120,941
+60,674
| +101% | +$2.38M |
|
388
ImmunityBio
IBRX
$7.51B
| $5.02M | 0.03% |
825,388
+374,349
| +83% | +$2.81M |
|
389
Crown Castle
CCI
$33.3B
| $4.99M | 0.03% |
23,908
-4,706
| -16% | -$869K |
|
390
Globe Life
GL
$14.2B
| $4.95M | 0.03% |
52,835
+4,743
| +10% | +$439K |
|
391
Invesco
IVZ
$13.1B
| $4.95M | 0.03% |
214,942
+28,669
| +15% | +$698K |
|
392
American Financial Group
AFG
$11.8B
| $4.91M | 0.03% |
35,771
+3,212
| +10% | +$442K |
|
393
Twist Bioscience
TWST
$5.7B
| $4.91M | 0.03% |
63,453
+37,791
| +147% | +$3.88M |
|
394
Fortune Brands Innovations
FBIN
$5.88B
| $4.89M | 0.03% |
53,578
-611
| -1% | -$52.9K |
|
395
HEICO Corp Class A
HEI.A
$36B
| $4.88M | 0.03% |
38,010
-13,465
| -26% | -$1.71M |
|
396
Myriad Genetics
MYGN
$270M
| $4.88M | 0.03% |
176,922
+83,152
| +89% | +$2.41M |
|
397
Huntington Ingalls Industries
HII
$12.9B
| $4.85M | 0.03% |
25,993
-2,588
| -9% | -$500K |
|
398
Editas Medicine
EDIT
$396M
| $4.83M | 0.03% |
181,771
+134,623
| +286% | +$4.63M |
|
399
Copart
CPRT
$27B
| $4.82M | 0.03% |
127,200
-4,984
| -4% | -$185K |
|
|
SI
400
DELISTED
Silvergate Capital Corporation
SI
| $4.81M | 0.03% |
32,479
-15,081
| -32% | -$2.58M |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q4 2021 Portfolio in Review
As of Q4 2021, Rafferty Asset Management held 1,362 positions worth $19B, up 30% from $14.6B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Rafferty Asset Management deployed $3.05B of net new capital in Q4 2021, opening 110 new positions and adding to 730 existing holdings. Its largest new stake was Aflac: 345,009 shares worth $20.1M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $81.8M trimmed.
- Rafferty Asset Management's largest Q4 2021 buy was Aflac: 345,009 shares worth $20.1M.
- Rafferty Asset Management added most to iShares Core S&P 500 ETF in Q4 2021, an estimated $492M increase.
- Rafferty Asset Management's biggest Q4 2021 reduction was VanEck Gold Miners ETF, cutting an estimated $81.8M.
- Rafferty Asset Management fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $8.07M.
- Rafferty Asset Management's ten largest holdings make up 40% of its $19B portfolio in Q4 2021.
- Rafferty Asset Management opened 110 new positions and closed 64 in Q4 2021.
- Rafferty Asset Management's portfolio value rose 30% quarter-over-quarter to $19B.
Based on Rafferty Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.